- Home
- MIST vs GHI Comparison
MIST vs GHI Comparison
Compare MIST & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIST | GHI |
|---|---|---|
| Founded | 2003 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 181.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MIST | GHI |
|---|---|---|
| Price | $1.70 | $7.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $8.50 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 2.1M | 74.3K |
| Earning Date | 03-12-2026 | 02-20-2026 |
| Dividend Yield | N/A | ★ 19.22% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | N/A | ★ $26,247,399.00 |
| Revenue This Year | N/A | $201.02 |
| Revenue Next Year | N/A | $2.87 |
| P/E Ratio | ★ N/A | $45.64 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $6.01 |
| 52 Week High | $3.06 | $13.29 |
Technical Indicators
Market Signals| Indicator | MIST | GHI |
|---|---|---|
| Relative Strength Index (RSI) | 34.51 | 50.08 |
| Support Level | $1.70 | $7.50 |
| Resistance Level | $1.89 | $7.82 |
| Average True Range (ATR) | 0.10 | 0.26 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 2.86 | 21.20 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.